Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Dana-Farber Cancer Institute
Fate Therapeutics
Ossium Health, Inc.
Therapeutic Advances in Childhood Leukemia Consortium
University of Pennsylvania
Anhui Provincial Hospital
University of Pennsylvania
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Fate Therapeutics
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
The Affiliated People's Hospital of Ningbo University
Loyola University
Therapeutic Advances in Childhood Leukemia Consortium
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Celularity Incorporated
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Duke University
Altor BioScience
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center